Foresight Global Investors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Buy
1,301
+18
+1% +$4.73K 0.22% 26
2026
Q1
$342K Buy
1,283
+10
+0.8% +$2.71K 0.22% 23
2025
Q4
$319K Hold
1,273
0.15% 24
2025
Q3
$365K Buy
+1,273
New +$341K 0.22% 21
2024
Q4
Sell
-6,075
Closed -$1.36M 30
2024
Q3
$1.36M Buy
6,075
+600
+11% +$132K 0.74% 22
2024
Q2
$1.11M Buy
+5,475
New +$1.11M 0.54% 35

Other funds holding LH

Foresight Global Investors's LH Position: Q2 2026 in Review

Foresight Global Investors increased its Labcorp (LH) stake by 1.4% in Q2 2026, buying an estimated $4.73K and bringing the position to 1,301 shares worth $364K. The position accounts for 0.22% of the portfolio, ranked #26.

Foresight Global Investors first reported a position in LH in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.36M in Q3 2024. 1,058 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Foresight Global Investors held 1,301 shares of Labcorp worth $364K as of Q2 2026.
  • Foresight Global Investors bought 18 Labcorp shares in Q2 2026, an estimated $4.73K.
  • Labcorp made up 0.22% of Foresight Global Investors's portfolio in Q2 2026, its #26 holding.
  • Foresight Global Investors first reported a position in Labcorp in Q2 2024 and has held it in 6 quarters since.
  • Foresight Global Investors's Labcorp position peaked at $1.36M in Q3 2024.
  • 1,058 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Foresight Global Investors's 13F filing for Q2 2026, filed 11 Aug 2026.